Published in Mol Biol (Mosk) on November 01, 2012
Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency. Mol Ther Oncolytics (2015) 0.94
Mechanisms of Oncolysis by Paramyxovirus Sendai. Acta Naturae (2015) 0.92
GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology (1995) 5.34
A variation in the structure of the protein-coding region of the human p53 gene. Gene (1988) 3.03
The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature (1998) 2.86
Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains. Proc Natl Acad Sci U S A (1996) 2.66
The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses. FEBS Lett (1992) 2.24
Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections. J Infect Dis (1999) 1.83
A comparison of the nucleotide sequences of eastern and western equine encephalomyelitis viruses with those of other alphaviruses and related RNA viruses. Virology (1993) 1.67
Characterization of the L gene and 5' trailer region of Ebola virus. J Gen Virol (1999) 1.63
Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway. Proc Natl Acad Sci U S A (2008) 1.36
The complete nucleotide sequence of the Popp (1967) strain of Marburg virus: a comparison with the Musoke (1980) strain. Arch Virol (1995) 1.33
Animal pathology of filoviral infections. Curr Top Microbiol Immunol (1999) 1.22
Chromosome changes caused by alterations of p53 expression. Mutat Res (1996) 1.22
Virus-based reporter systems for monitoring transcriptional activity of hypoxia-inducible factor 1. Gene (2005) 1.07
[Complete nucleotide sequence of the Eastern equine encephalomyelitis virus genome]. Mol Gen Mikrobiol Virusol (1991) 1.01
Disruption of actin microfilaments by cytochalasin D leads to activation of p53. FEBS Lett (1998) 1.00
The VP35 and VP40 proteins of filoviruses. Homology between Marburg and Ebola viruses. FEBS Lett (1993) 0.94
Activation of p53-mediated cell cycle checkpoint in response to micronuclei formation. J Cell Sci (1998) 0.94
P53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints. Oncogene (1999) 0.94
p53 does not control the spindle assembly cell cycle checkpoint but mediates G1 arrest in response to disruption of microtubule system. Cell Biol Int (1999) 0.93
p53 activation in response to microtubule disruption is mediated by integrin-Erk signaling. Oncogene (2001) 0.93
The GP-protein of Marburg virus contains the region similar to the 'immunosuppressive domain' of oncogenic retrovirus P15E proteins. FEBS Lett (1993) 0.92
[Primary structure of the full-size DNA copy of the influenza virus A/Kiev/59/79 (H1N1) PB1 gene protein]. Bioorg Khim (1987) 0.90
Genetic diversity of hantaviruses associated with hemorrhagic fever with renal syndrome in the far east of Russia. Virus Res (2000) 0.90
[Retroviral reporter systems for the assessment of activity of stress-induced signal transduction pathways controlled by p53, HIF-1 and HSF-1 transcription factors]. Mol Biol (Mosk) (2005) 0.90
Local administration of cells containing an inserted IL-2 gene and producing IL-2 inhibits growth of human tumours in nu/nu mice. Immunol Lett (1988) 0.89
Optimization of a Genome-Wide Disordered Lentivector-Based Short Hairpin RNA Library. Mol Biol (2006) 0.89
Complete nucleotide sequences of Marburg virus genes 5 and 6 encoding VP30 and VP24 proteins. Biochem Mol Biol Int (1995) 0.88
[Transcriptional inhibition of human papilloma virus in cervical carcinoma cells reactivates functions of the tumor suppressor p53]. Mol Biol (Mosk) (2007) 0.86
Cell-specific effects of RAS oncogene and protein kinase C agonist TPA on P-glycoprotein function. FEBS Lett (1995) 0.86
Restoration of p53 tumor-suppressor activity in human tumor cells in vitro and in their xenografts in vivo by recombinant avian adenovirus CELO-p53. Gene Ther (2004) 0.86
[Effect of on various cell lines of p53 cDNA, expressed under the control of an exogenous homologous promotor]. Mol Biol (Mosk) (1995) 0.86
[Functional heterogeneity of p53-responsive elements]. Mol Biol (Mosk) (1996) 0.85
[Down-regulation of TRIP6 expression induces actin cytoskeleton rearrangements in human carcinoma cell lines]. Mol Biol (Mosk) (2005) 0.84
[Downregulation of activated leukemic oncogenes AML1-ETO and RUNX1(K83N) expression with RNA-interference]. Mol Biol (Mosk) (2010) 0.83
[Genetic identification of the Crimean-Congo hemorrhagic fever virus during epidemic outbreak in Kazakhstan in 2000]. Mol Gen Mikrobiol Virusol (2002) 0.82
Molecular epidemiology of the hepatitis C virus in Western Siberia. J Med Virol (2005) 0.82
[Structural organization of the human p53 gene. I. Molecular cloning of the human p53 gene]. Genetika (1987) 0.82
Highly pathogenic influenza virus H5N1 found in western Siberia is genetically related to viruses that circulated in Southeast Asia in 2003-2005. Dokl Biol Sci (2006) 0.82
[Characteristics of Crimean-Congo hemorrhagic fever virus circulating in Russia and Central Asia]. Vopr Virusol (2002) 0.82
Transcription of the viral genome in cell lines transformed by simian virus 40. I. Mapping of virus-specific nuclear RNAs. Nucleic Acids Res (1980) 0.81
[Isolation of a plasmid clone containing the mRNA sequence for mouse nonviral T-antigen]. Dokl Akad Nauk SSSR (1982) 0.81
Localization of four antigenic sites involved in Venezuelan equine encephalomyelitis virus protection. Arch Virol (1994) 0.81
[Comparison of the amino acid sequence of structural proteins from attenuated and pathogenic strains of the Venezuelan equine encephalomyelitis virus]. Dokl Akad Nauk SSSR (1991) 0.81
[The 2003 results of monitoring of influenza A virus in the populations of wild birds in the south of Western Siberia]. Vopr Virusol (2006) 0.81
[Alternative transcripts from POLRMT responsible for synthesis of nuclear RNA polymerase IV]. Mol Biol (Mosk) (2005) 0.81
[A new genetic variant of the PUUV virus from the Maritime Territory and its natural carrier red-grey vole Clethrionomys rufocanus]. Vopr Virusol (2004) 0.80
[Genetic diversity of group A rotavirus isolates found in Western Siberia in 2007-2011]. Mol Gen Mikrobiol Virusol (2012) 0.80
[Construction of a reporter system for fine quantitative assessment of activity of p53 protein in cultured cells]. Mol Biol (Mosk) (2004) 0.80
[The immunogenic properties of a recombinant vaccinia virus with an incorporated DNA copy of the 26S RNA of the Venezuelan equine encephalomyelitis virus]. Vopr Virusol (1994) 0.79
[Genome-wide lentivector-based pooled shRNA library optimization]. Mol Biol (Mosk) (2006) 0.79
Distinct effects of various p53 mutants on differentiation and viability of human K562 leukemia cells. Oncol Res (1997) 0.79
[The protective role of p53 in Ras-induced transformation of REF52 cells]. Mol Biol (Mosk) (2003) 0.79
[Apoptin enhances the oncolytic activity of vaccinia virus]. Mol Biol (Mosk) (2014) 0.79
Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts. Oncol Res (1995) 0.79
[Antisense RNA p53 inhibits proliferation of normal and transformed cells]. Mol Biol (Mosk) (1989) 0.78
[Effect of inactivating the p33ING1 tumor suppressor on the function of cell cycle "checkpoints" and genome stability]. Genetika (2000) 0.78
[P66shc action on resistance of colon carcinoma RKO cells to oxidative stress]. Mol Biol (Mosk) (2012) 0.78
Constitutive and induced functions of the p53 gene. Biochemistry (Mosc) (2010) 0.78
Human recombinant laminin-binding protein: isolation, purification, and crystallization. Biochemistry (Mosc) (2000) 0.78
[Oncolytic poxviruses]. Mol Gen Mikrobiol Virusol (2012) 0.78
[Oncolytic enteroviruses]. Mol Biol (Mosk) (2012) 0.78
Genetic analysis of the M RNA segment of Crimean-Congo hemorrhagic fever virus strains involved in the recent outbreaks in Russia. Arch Virol (2004) 0.78
[The human adenosine deaminase gene contains a p53-responsive element]. Dokl Akad Nauk (1996) 0.77
[Comparative study of the morphology and antigenic properties of recombinant analogs of a Marburg virus nucleoprotein]. Mol Biol (Mosk) (2001) 0.77
[ELISA and RT-PCR-based research of viruses in the ticks collected in the foci of Crimean-Congo fever in Kazakhstan and Tajikistan in 2001-2002]. Vopr Virusol (2005) 0.77
[Molecular genetic characteristics of astroviruses circulating in Novosibirsk]. Vopr Virusol (2011) 0.77
[Genetic characteristics of the S-segment of RNA from two strains of the Crimean-Congo hemorrhagic fever virus isolated in the south of Russia and in Uzbekistan]. Vopr Virusol (2003) 0.77
[Two allelic genes of human p53 code for proteins differing with respect to amino acid sequence]. Genetika (1988) 0.77
[Surveillance for avian influenza virus in synanthropic birds during epizootic and postepizootic periods on the south of west Siberia]. Zh Mikrobiol Epidemiol Immunobiol (2007) 0.77
[Effect of mutations in genes of Venezuelan equine encephalomyelitis virus structural proteins on its attenuation]. Dokl Akad Nauk (1992) 0.77
[Recombinant equine Venezuelan encephalomyelitis virus, expressing HBsAg]. Dokl Akad Nauk (1993) 0.77
The use of syngeneic cells producing human somatotropic hormone (hSTH) for immunization of mice and development of hybridomas. Hybridoma (1990) 0.77
[Protein complementation as tool for studying protein-protein interactions in living cells]. Mol Biol (Mosk) (2012) 0.77
[Oncotoxic proteins in cancer therapy: mechanisms of action]. Mol Biol (Mosk) (2015) 0.76
[Frequency of encountering markers of viral hepatitis A, B, and C in the aboriginal inhabitants of the northwest region of Siberia]. Vopr Virusol (1995) 0.76
[Immunobiological properties of vp24 protein of Ebola virus expressed by recombinant vaccinia virus]. Vopr Virusol (1997) 0.76
[Study of virus contamination of Ixodes ticks in the foci of Crimean-Congo hemorrhagic fever in Kazakhstan and Tajikistan]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.76
[Construction of chimeric tumor suppressor p53 resistant to the dominant-negative interaction with p53 mutants]. Mol Biol (Mosk) (2002) 0.76
[Immunogenicity of a recombinant strain of vaccinia virus, expressing a Venezuelan equine encephalomyelitis virus structural protein gene in peroral immunization]. Vopr Virusol (2001) 0.76
[Occurrence of markers, distribution of genotypes and risk factors for viral hepatitis C among some groups of the population in the Novosibirsk region]. Zh Mikrobiol Epidemiol Immunobiol (2004) 0.76
[Nucleotide sequence of genes and complete amino acid sequence of tick-borne encephalitis virus strain 205]. Mol Gen Mikrobiol Virusol (1991) 0.76
[The occurrence rate of HGV/GBV-C RNA and risk factors in patients of narcological dispensary in Novosibirsk]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.76
A comparison of the nucleotide sequences of eastern and western equine encephalomyelitis viruses with those of other alphaviruses and related RNA viruses. Virology (1994) 0.76
[Mutation of p53 is necessary for stable transformation of REF52 cells by myc+ras oncogenes]. Mol Biol (Mosk) (2000) 0.76
[Oncolytic parvoviruses. A new approaches for cancer therapy]. Vestn Ross Akad Med Nauk (2012) 0.76
[Enhanced control of proliferation in telomerized cells]. Ontogenez (2007) 0.76
[Highly pathogenic avian influenza: a new pandemic threat and possibilities to resist it]. Vestn Ross Akad Med Nauk (2006) 0.76
[A lentivirus vector based assay system for quantitative detection of intracellular translocations of recombinant proteins]. Mol Biol (Mosk) (2009) 0.76
[Primary structure of proteins of the nsP2 and nsP3 polymerase complex confirm the recombinant nature of western encephalitis virus]. Dokl Akad Nauk (1994) 0.76
[Hepatitis B markers in southern Altaĭ inhabitants of the village of Mendur-Sokkon (the Republic of Altaĭ). HBsAg subtyping in hepatitis B virus isolates with monoclonal antibodies]. Zh Mikrobiol Epidemiol Immunobiol (2001) 0.76
[Induction of hyperdiploidy and chromosome breaks in LIM1215 cells expressing the exogenous mutant p53]. Genetika (1996) 0.75
[Oncolytic properties of some orthopoxviruses, adenoviruses and parvoviruses in human glioma cells]. Vestn Ross Akad Med Nauk (2013) 0.75
A chemical method to enrich RNA by molecules having 5'-terminal triphosphate groups. Nucleic Acids Res (1981) 0.75